Neurocognitive outcomes decades after treatment for childhood acute lymphoblastic leukemia: a report from the St Jude lifetime cohort study
KR Krull, TM Brinkman, C Li, GT Armstrong… - Journal of Clinical …, 2013 - ascopubs.org
Purpose To determine rates, patterns, and predictors of neurocognitive impairment in adults
decades after treatment for childhood acute lymphoblastic leukemia (ALL). Patients and …
decades after treatment for childhood acute lymphoblastic leukemia (ALL). Patients and …
The treatment of adolescents and young adults with acute lymphoblastic leukemia
J Lukenbill, AS Advani - Current hematologic malignancy reports, 2013 - Springer
Adolescents and young adult (AYA) patients with acute lymphoblastic leukemia (ALL), 16–
40 years of age, were historically not the focus of prospective studies on ALL treatment. This …
40 years of age, were historically not the focus of prospective studies on ALL treatment. This …
Neuropsychological outcomes of a randomized trial of prednisone versus dexamethasone in acute lymphoblastic leukemia: findings from Dana‐Farber Cancer …
DP Waber, M McCabe, M Sebree… - Pediatric blood & …, 2013 - Wiley Online Library
Background Dexamethasone is more efficacious than prednisone in the treatment of acute
lymphoblastic leukemia (ALL), but has also been associated with greater toxicity. We …
lymphoblastic leukemia (ALL), but has also been associated with greater toxicity. We …
Effects of early chemotherapeutic treatment on learning in adolescent mice: implications for cognitive impairment and remediation in childhood cancer survivors
EB Bisen-Hersh, PN Hineline, EA Walker - Clinical Cancer Research, 2013 - AACR
Purpose: Among children diagnosed with acute lymphoblastic leukemia (ALL) and given
chemotherapy-only treatment, 40% to 70% of survivors experience neurocognitive …
chemotherapy-only treatment, 40% to 70% of survivors experience neurocognitive …
[PDF][PDF] Dawki tolerancji dla narządów krytycznych w radioterapii chorych na raka głowy i szyi
M Hutnik, K Składowski, A Wygoda… - Nowotwory Journal of …, 2013 - core.ac.uk
Współczesna radioterapia wykorzystuje różnorodne techniki podawania promieniowania
oraz różnorodne dawki jego frakcjonowania. Radioterapia konformalna rozumiana zarówno …
oraz różnorodne dawki jego frakcjonowania. Radioterapia konformalna rozumiana zarówno …
Role of NOS3 DNA variants in externalizing behavioral problems observed in childhood leukemia survivors
S Marcoux, P Robaey, A Gahier… - Journal of Pediatric …, 2013 - journals.lww.com
Objective: Neuropsychological problems occurrence varies among childhood cancer
survivors, and associated risk factors have not been fully deciphered. We wanted to study …
survivors, and associated risk factors have not been fully deciphered. We wanted to study …
Longitudinal language outcomes following intrathecal chemotherapy for acute lymphoblastic leukaemia
FM Lewis, ML Perry, BE Murdoch - International Journal of Speech …, 2013 - Taylor & Francis
Intrathecal chemotherapy (ITC) is the treatment option for acute lymphoblastic leukaemia
(ALL). Neurocognitive deficits have been described following ITC, but language status post …
(ALL). Neurocognitive deficits have been described following ITC, but language status post …
[PDF][PDF] A radiological and radiotherapeutic approach for paediatric tumours in the head and neck area
A Zygogianni, G Kyrgias, J Kouvaris… - Head Neck …, 2013 - academia.edu
The most common paediatric malignancies in the head and neck area consisted of
lymphoma, leukaemia, brain tumours, neuroblastoma, Wilms' tumour, sarcomas and primary …
lymphoma, leukaemia, brain tumours, neuroblastoma, Wilms' tumour, sarcomas and primary …
Childhood acute lymphoblastic leukemia: A lifespan perspective.
KR Krull, T Brinkman - 2013 - psycnet.apa.org
Acute lymphoblastic leukemia (ALL) is the most common form of childhood cancer,
accounting for roughly 30% of new cancer diagnoses (Howlander et al., 2010). Although the …
accounting for roughly 30% of new cancer diagnoses (Howlander et al., 2010). Although the …
[PDF][PDF] Tolerance doses of critical organs in patients with head and neck cancer treated with radiation therapy
M Hutnik, K Składowski, A Wygoda… - … Journal of Oncology, 2013 - journals.viamedica.pl
Dawki tolerancji dla narządów krytycznych w radioterapii chorych na raka głowy i szyi Page
1 35 Artykuł przeglądowy • Review article NOWOTWORY Journal of Oncology 2013, volume …
1 35 Artykuł przeglądowy • Review article NOWOTWORY Journal of Oncology 2013, volume …